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Silvano Esposito, (*I and Vittorio Carnellicl) 
Background: The identification of patient management practices and the sources of medical information is crucial 
for rationalizing the treatment of respiratory tract infections, whose high incidence, especially in children, makes them 
one of the maior areas of unnecessary health expenditure. 
Materials and Methods: This national prospective study was designed to investigate the diagnostic and prescribing 
habits of 100 office-based pediatricians managing upper respiratory tract infections in 1111 pediatric patients (604 
males, mean age 6.7952.77 years; 507 females, mean age 6.7322.8 years) sequentially enrolled when an antibiotic 
treatment was deemed necessary. 
Results: The most frequently diagnosed diseases were acute tonsillopharyngitis (56.2%) and acute otitis media 
(18.1%). Penicillins were prescribed in 34.3% of the cases, cephalosporins in 38.1%, and macrolides in 26.1%: oral 
drugs accounted for 92.2% of the prescriptions. The treatments were administered once or twice daily in 75.8% of 
the patients, and prescribed for ~8 days in more than 80%; 76.7% also received supportive or symptomatic treatment 
(antipyretics, corticosteroids, cough suppressants and non-steroidal anti-inflammatory drugs). Laboratory or radio- 
logic investigations were rarely requested. The main sources of medical information indicated by the participating 
pediatricians were pharmaceutical companies (35.6%) and meeting or congress reports (27.3%). 
Conclusions: The results indicate that more active education is still needed to improve the decision-making processes 
of office-based pediatricians. 
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INTRODUCTION 
The management of acute upper respiratory infections 
(URIS) in children is one of the major tasks of office- 
based pediatricians. Young children may experience 
several episodes a year, and, although frequently of viral 
origin, these may lead to secondary bacterial infections 
such as otitis media and sinusitis.] The increasing in- 
cidence of the infections can be attributed to the grow- 
ing use of daycare centers (especially in large cities and 
if both parents work) and the effects of smoking and air 
pollutants. 
The treatment of respiratory tract infections fre- 
quently involves the use of antibiotics, which represent 
the second most commonly prescribed group of drugs 
and are mainly prescribed for infections diagnosed in 
ambulatory settings. * However, the predominance of 
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viral etiologies raises doubts about the real efficacy of 
such treatments,3j4 and the widespread use of, parti- 
cularly, the new extended-spectrum oral compounds has 
contributed to the emergence of increasingly resistant 
bacterial strains.j 
Acute URIS not only represent a health problem in 
terms of the costs of diagnosis and treatment, but also 
have considerable non-medical implications. They have 
a considerable socio-economic impact because, as they 
are usually only mildly or moderately severe, the affected 
children are normally cared for at home, which means 
that a member of the family has to stay with them (with 
a consequent loss of working days) or a baby-sitter needs 
to be hired. 
Only limited prospective data are currently avail- 
able concerning the medical and social impact of pediatric 
URIs, which makes it difficult to document their medical 
and social costs. The relatively few studies of antibiotic 
drug use are usually based on overall statistics or small 
populations,W and cannot provide an adequate descrip- 
tion of the complete medical and social process. 
This national survey was carried out in Italy in 
January-March 1998 and designed to investigate how 
office-based pediatricians manage the primary care of 
URIS. 
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METHODS Table 1. Upper respiratory tract infections by diagnosis 
This was a prospective observational study aimed at 
documenting the procedures used by 100 National 
Health Service office-based pediatricians throughout 
Italy in managing children with community-acquired 
URIS requiring antibiotic treatment. The physicians 
were selected on the basis of criteria such as age, time 
since qualification, and patient allotments, and asked to 
enrol consecutively at least the first 10 patients aged 
23-16 years requiring, according to the pediatrician’s 
judgment, an antibiotic treatment course. No financial 
incentives were offered. 
A clinical chart was prepared on which to record 
the patients’ demographic information, clinical data, 
infection-related symptoms, concomitant pathologies, 
prescribed antibiotics and other drugs, and requested 
laboratory (hematology, throat and nasal swabs) or radio- 
logic investigations. The physicians were also asked to 
record the reason(s) for the choice of antibiotic, and the 
sources of their information and education concerning 
antibiotic therapy. 
Acute pharyngotonsillitis 
Acute otitis media 
Recurrent pharyngitis 
Sinusitis 
Tracheitis 
External otitis 
Chronic otitis 
Rhinitis 
Influenza 
Acute pharyngitis 
Bronchitis 
Laryngitis 
Other 
No. of patients Percentage 
625 56.2 
201 18.1 
105 9.4 
52 4.6 
27 2.5 
20 1.8 
16 1.4 
11 1.0 
10 0.9 
8 0.8 
4 0.4 
3 0.3 
29 2.6 
Treatments 
Antibiotics 
A second examination was planned for the patients 
whose clinical condition had not normalized or if it 
was otherwise deemed necessary. In such cases, the 
physicians also recorded the disappearance or otherwise 
of the symptoms, any adverse event observed, and their 
judgment of the clinical results of the treatment. 
The prescribed antibacterial treatments included a 
wide range of compounds. As shown in Table 2, 
penicillins were prescribed in 34.3% of the patients, the 
most frequently used being amoxicillin and amoxicillin- 
clavulanate (45.9% and 44.6% of penicillin prescrip- 
tions, and 15.8% and 15.3% of all prescriptions). Oral 
ampicillin (together with its pro-drug bacampicillin or in 
combination with sulbactam) accounted for 5.3% of the 
penicillin prescriptions (1.76% of all prescriptions). 
The social impact of URIS was investigated by 
asking the parents how many schooldays had been lost, 
whether the illness had required them to take time off 
work, and whether they had to hire a baby-sitter to care 
for the child. 
The data were analyzed using SAS version 6.97 
software. All of the collected data were descriptively 
analyzed. Frequency distributions were used for discrete 
data; the continuous variables were described in terms 
of mean frequencies, standard deviations, and mean, 
minimum and maximum values. 
Of the 12 cephalosporins, 42.4% were third-genera- 
tion and 39.2% second-generation oral compounds; the 
most frequently prescribed drugs in these two groups 
were cefixime and cefaclor (23.9% and 26.2% of the 
cephalosporin prescriptions; 9.1% and 10% of all 
prescriptions). Third-generation parenteral extended- 
spectrum cephalosporins were used in 17% of the cases 
(6.7% of all prescriptions). 
Macrolides accounted for 26.1% of all prescriptions, 
the most frequently administered being clarithromycin 
(45.4%; 11.9% of all prescriptions) and azithromycin 
(31.1%; 8.1% of all prescriptions). 
RESULTS 
Patients and diagnoses 
Between January and March 19981111 pediatric patients 
(604 males, mean age 6.7922.77 years; 507 females, mean 
age 6.73k2.8 years) were recruited. Ninety-one (8.2%) 
had a history of allergy, which was mainly respiratory 
(5.2%). 
The three main drug classes were equally prescribed 
for acute PT (34.1% penicillins; 34.8% cephalosporins; 
30.1% macrolides), with second- and third-generation 
oral cephalosporins being prescribed in, respectively, 
11.7% and 15.7% of the cases, and parenteral com- 
pounds in 7.4%. Penicillins, cephalosporins and macro- 
lides were prescribed in, respectively, 34.8%, 47.6% and 
14.4% of the patients with AOM. 
The examinations took place in the pediatricians’ 
offices (61.1%) or the patients’ homes (38.9%). The 
majority of the children (82.6%) were examined l-3 
days after the onset of symptoms. 
Oral antibiotics were used in 92.2% of the patients 
and parenteral drugs in 7.5%. Once- or twice-daily 
regimens were used in 78.5% of the cases, and more 
than 80% of the patients were treated for 28 days. 
The predominant diagnosis was pharyngotonsillitis 
(PT: 56.2%), followed by acute otitis media (AOM: 
18.1%) and recurrent pharyngitis (9.4%); the other diag- 
noses were much less frequent (Table 1). The diseases 
were classified as mild, moderate or severe in, respect- 
ively, 22.4%, 70.8% and 6.8% of the cases. 
Supportive and symptomatic treatment 
Supportive or symptomatic treatment was prescribed in 
76.7% of the patients: 49.6% received one drug, 18.8% 
two, and 8.4% three or more. Antipyretics were the 
most frequently used (49.8%), followed by mucolytics 
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Table 2. Antibiotic prescriptions Follow-up visits 
% of % of 
No. of Antibiotic Total 
Prescriptions C/ass Prescriptions 
Penicillins 381 - 34.3 
Amoxicillin 175 45.9 15.8 
Amoxicillin-clavulanate 170 44.6 15.3 
Ampicillin 1 0.3 0.08 
Ampicillin-sulbactam 1 0.3 0.08 
Benzathine G penicillin 6 1.6 0. 
Bacampicillin 18 4.7 1.6 
Flucloxacillin 10 2.6 0.9 
Total intramuscularly 6 1.6 0.5 
Cephalosporins 
Cefetamet pivoxyl 
Cefixime 
Cefodizime 
Cefonicid 
Cefotaxime 
Cefpodoxime proxetii 
Ceftazidime 
Ceftibuten 
Ceftriaxone 
Cefuroxime axetil 
Cefazolin 
Cefaclor 
Third-generation oral 
cephalosporins 
Second-generation oral 
cephalosporins 
Third-generation 
parenteral cephalosporins 
First-generation 
parenteral cephalosporins 
423 
13 
101 
2 
6 
4 
7 
11 
58 
51 
55 
4 
111 
3.1 
23.9 
0.5 
1.4 
0.9 
1.7 
2.6 
13.7 
12.1 
13 
0.9 
26.2 
38.1 
1.2 
9.1 
0.2 
0.5 
0.4 
0.6 
1 
5.2 
4.5 
5 
0.3 
10 
179 42.4 16.1 
166 39.2 15 
74 17.1 6.7 
4 0.9 0.36 
Macrolides 290 - 26.1 
Clarithromycin 132 45.4 11.9 
Josamycin 2 0.7 0.2 
Miocamycin 3 1.1 0.3 
Roxithromicin 63 21.7 5.7 
Azithromicin 90 31.1 8.1 
Others 
Rufloxacin 
Tiamfenicol 
Trimethoprim- 
Sulfamethoxazole 
Rifamicin 
17 
5.8 
5.8 
1.5 
0.08 
0.08 
14 82.6 1.3 
5.8 0.08 
(15.5%) corticosteroids (9.8%) cough suppressants 
and non-steroidal anti-inflammatory drugs (4.4%). Oral 
administration was preferred (49.2%) followed by the 
use of rectal suppositories (30.7%). 
Laboratory and radiologic investigations 
and specialist consultations 
The pediatricians rarely felt it necessary to request 
microbiological or serologic investigations. A throat 
culture was made before starting PT treatment in 
111/625 cases (17.8%), and a complete blood count with 
differential and the determination of acute-phase 
reactants in only 77/1111 (6.9%). 
Radiologic studies (mainly chest or paranasal sinus 
X-rays) were requested for 35 subjects. 
Fifty-four ENT and 12 allergologic specialist consul- 
tations were requested. 
Four hundred and fifty-two patients (40.7%) were 
followed up (74.8% office visits; 12.6% home visits; 
12.6% phone consultations): the reason was persisting 
signs and symptoms indicating possible treatment failure 
in 13.7% of cases (36.9% were judged to be responding). 
New symptoms were recorded in 41 patients (9.1%). 
Twenty per cent of the treatment failures were 
switched to another drug, which was a parenteral com- 
pound in 30.6% of the cases. The main reasons for the 
changes were persisting signs and symptoms and 
possible microbiological failure. 
Eighty-nine of the patients underwent a third 
and final check-up, at which 98.1% were cured or had 
markedly improved. 
Tolerability 
The treatments were generally well tolerated. Ninety- 
four adverse events were recorded in 74 (16%) of the 
452 patients. Diarrhea was documented in 43 patients 
(mild in 41, possibly iatrogenic in 27) nausea in 14, 
vomiting in 11, gastric discomfort in 13, rash in 9, and 
itching in 2. Two cases were undetermined. 
Reasons for antibiotic choice 
The reasons for the choice of drug were a high degree 
of antimicrobial activity in (only) 30.4% of the cases, 
treatment compliance in 17.2%, general tolerability 
in 14%, and cost-effectiveness in 10.3%. Twenty-six 
per cent of the prescriptions were based on the patient’s 
personal experience with a specific antibiotic treatment 
(indicating a substantial demand for an ‘authorized’ 
form of self-medication), whereas the personal exper- 
ience of the physicians themselves accounted for no 
more than 2.1%. 
Sources of information on antibiotics 
Table 3 shows that books or scientific journals were 
reported as the main source of continuing education on 
antibiotic treatment by only 9.9% of the physicians, 
whereas 22% obtained their information from non-peer- 
reviewed bulletins. Medical meetings were cited in 
27.3% of the reports. The substantial impact of non- 
Table 3. Sources of continuing education 
Percentage of 
Answers 
Meetings 
NHS courses 
Pharmaceutical company courses 
Information directly provided by 
pharmaceutical companies 
Newsletters 
Scientific books or journals 
Personal experience 
27.3 
3.6 
5.8 
29.8 
22.2 
9.9 
1.4 
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independent education is indicated by the fact that 
35.6% of the reports cited pharmaceutical company 
promotional meetings and direct information. 
Family impact of URIS 
Normal family life was frequently affected. Only 2.4% 
of the children did not lose any day of school, whereas 
15.4% lost 1-3 days, 73.4% lost 4-8 days, and 8.9% lost 
10 or more days. 
Furthermore, 18.1% of the parents reported that 
they had had to take days off work, and 4.2% of those 
who could not lose working days had to hire a baby- 
sitter to care for their child. 
DISCUSSION 
Acute URIS comprise the most frequent medical reason 
for visiting a physician’s office. In a large European 
observational cohort study,9 they accounted for 44.8% 
of 1466 visits. Furthermore, 22.7% involved children 
aged ~10 years, who were prescribed 31.2% of all of the 
antibiotics prescribed for URIS. 
‘Ihe accurate diagnosis and treatment of acute URIS 
in children is difficult for various reasons, First, the 
diagnostic criteria are vague: for example, AOM is diag- 
nosed by some practitioners when they find myringitis, 
and by others only when there is redness, dullness and 
purulent material behind the tympanic membrane. 
Second, even if the clinical diagnosis is sound, therapy 
is still empirical because of the lack of pathogen tests: for 
example. microbiological confirmation is rarely available 
in the case of otitis and sinusitis, and acute pharyngitis 
is the only clinical condition in which the main causative 
bacteria (group A /3-hemolytic streptococci-GABHS) 
can be easily demonstrated by means of a standard 
throat culture or rapid antigen testing.‘O Finally, the 
difficulty in distinguishing antibiotic-responding diseases 
from those of viral origin leads to overtreatment. 
Further pressure to use antimicrobial agents in out- 
patient settings may come from non-medical considera- 
tions, including patients’ (or parents’) expectations and 
previous experiences, and the physician’s desire not to 
alienate the patient.” 
As general pediatricians often consider acute URIS 
to be benign and spontaneously resolving clinical 
entities, the propensity to prescribe antibiotics may 
partially arise from the belief that they are effective in 
reducing complications, particularly pneumonia. How- 
ever, the protective advantage of antibiotics over placebo 
against such complications has been estimated in a 
review of 12 randomized clinical trials,‘* in which a 
relative risk of 0.71 (95% CI: 0.45-1.12) was calculated, 
thus indicating that 35 children need to be treated in 
order to prevent one case of complications. 
The main concern of general pediatricians is to 
provide symptom relief and reassure mothers that their 
children’s illness is being adequately considered and 
appropriately treated; antibiotics are the only available 
approach, because of the lack of major signs and symp- 
toms indicating a viral etiology. Complete blood counts 
or acute-phase reactants (such as C-reactive protein or 
the erythrocyte sedimentation rate) might help in 
differential diagnosis, but are only available in offices 
with at least basic laboratory facilities (which are rare in 
Italy and many other countries). 
Although PT can be etiologically diagnosed, this is 
rarely done, and treatment is generally prescribed 
without any microbiological investigation: one study13 
found that 76% of the patients with acute tonsillo- 
pharyngitis received full courses of antibiotics before 
the test results were available. 
Pediatricians are aware of the importance of 
tailoring treatment on the basis of the expectations 
of individual patients. Global patient acceptance is 
essential to ensure that the treatment is completed as 
indicated and not modified (or interrupted) when the 
symptoms disappear. This is particularly important in 
the case of tonsillopharyngitis, as the duration of treat- 
ment is directly related to the GABHS eradication rate. 
The range of prescribed non-antibacterial treat- 
ments is mainly limited to antipyretics and mucolytics, 
and aimed at ensuring rapid relief and the effective 
control of signs and symptoms. 
The frequency of URIS make them a problem for 
working families: 76.1% of the children in this study 
could not go to school or a daycare center for 3-7 days, 
and required home care by one of the parents or a paid 
baby-sitter. 
It is not our aim to judge the magnitude or quality of 
the antibiotic treatment documented in this study. Like 
most of their counterparts in the Western world, Italian 
physicians are faced with the fact that children experience 
repeated URI episodes during the autumn and winter, 
with the children of working parents sent to daycare 
centers being exposed to a 1.7-2.2 relative risk.i4J5 
Parental pressure to prescribe may be difficult to 
resist, and it is time-consuming to explain the reasons for 
not prescribing. In a recent survey of 915 office-based 
pediatricians, l6 48% reported that parents pressure 
them to prescribe antibiotics even when they are not 
considered to be indicated. Furthermore, some physicians 
may consider prescribing because of the placebo effect.” 
Thousands of guidelines aimed at providing a 
rationale for every clinical condition have been pub- 
lished throughout the world, but the misuse of anti- 
biotics has not significantly changed. A new approach is 
now needed, and should be based on rapid ‘bedside’ 
diagnostic facilities and simplified treatment schedules 
that maximize patient compliance. 
‘It is a long way from the Petri dish to community 
pediatrics’, and only continuing collaboration between 
pediatricians and general practitioners, and between 
science and society, will help us to understand the com- 
plex medical and social dynamics of acute community- 
acquired infections such as URIS. 
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